Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$870M |
| 2 |
Microsoft
MSFT
|
+$741M |
| 3 |
Apple
AAPL
|
+$512M |
| 4 |
Linde
LIN
|
+$488M |
| 5 |
Home Depot
HD
|
+$370M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$765M |
| 2 |
Charter Communications
CHTR
|
+$572M |
| 3 |
Energy Transfer Partners
ET
|
+$311M |
| 4 |
Bank of America
BAC
|
+$283M |
| 5 |
Coty
COTY
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.4% |
| 2 | Healthcare | 12.9% |
| 3 | Financials | 12.6% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Insmed
INSM
$22.4B
| $4.65M | ﹤0.01% |
181,616
-9,302
| -5% | -$259K |
|
|
OXFD
1802
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.65M | ﹤0.01% |
337,812
+169,031
| +100% | +$2.59M |
|
1803
PennyMac Financial
PFSI
$4.47B
| $4.62M | ﹤0.01% |
208,448
-68,776
| -25% | -$1.53M |
|
1804
Moelis & Co
MC
$4.85B
| $4.61M | ﹤0.01% |
132,080
-43,812
| -25% | -$1.58M |
|
|
TECX
1805
Tectonic Therapeutic
TECX
$536M
| $4.61M | ﹤0.01% |
23,618
-282
| -1% | -$60.8K |
|
1806
United States Oil Fund
USO
$2.15B
| $4.59M | ﹤0.01% |
47,620
-24,912
| -34% | -$2.48M |
|
|
MCF
1807
DELISTED
Contango Oil & Gas Co.
MCF
| $4.58M | ﹤0.01% |
2,634,823
-55,039
| -2% | -$144K |
|
|
EVOP
1808
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $4.57M | ﹤0.01% |
144,929
+107,241
| +285% | +$3.13M |
|
1809
Coca-Cola Consolidated
COKE
$12.8B
| $4.57M | ﹤0.01% |
152,640
+51,990
| +52% | +$1.63M |
|
1810
Methode Electronics
MEI
$458M
| $4.56M | ﹤0.01% |
159,786
+130,714
| +450% | +$3.66M |
|
1811
Axsome Therapeutics
AXSM
$11.7B
| $4.56M | ﹤0.01% |
+177,112
| New | +$3.55M |
|
1812
Synaptics
SYNA
$4.05B
| $4.55M | ﹤0.01% |
156,321
+38,588
| +33% | +$1.26M |
|
1813
Liberty Broadband Class A
LBRDA
$4.89B
| $4.55M | ﹤0.01% |
44,257
+29,180
| +194% | +$2.87M |
|
1814
Brookfield Infrastructure Partners
BIP
$19.6B
| $4.55M | ﹤0.01% |
177,962
+141,795
| +392% | +$3.53M |
|
1815
Mistras Group
MG
$477M
| $4.53M | ﹤0.01% |
315,304
-76,619
| -20% | -$1.05M |
|
1816
Cirrus Logic
CRUS
$6.76B
| $4.51M | ﹤0.01% |
103,174
-316,098
| -75% | -$13.7M |
|
1817
Philips
PHG
$25.5B
| $4.51M | ﹤0.01% |
130,116
-73,479
| -36% | -$2.36M |
|
1818
EXL Service
EXLS
$5.46B
| $4.5M | ﹤0.01% |
340,610
-94,975
| -22% | -$1.16M |
|
|
KW
1819
DELISTED
Kennedy-Wilson Holdings
KW
| $4.5M | ﹤0.01% |
218,695
-31,123
| -12% | -$662K |
|
1820
Toyota
TM
$228B
| $4.49M | ﹤0.01% |
36,224
+1,513
| +4% | +$185K |
|
1821
The Greenbrier Companies
GBX
$1.57B
| $4.49M | ﹤0.01% |
147,714
-9,198
| -6% | -$292K |
|
|
NTUS
1822
DELISTED
Natus Medical Inc
NTUS
| $4.48M | ﹤0.01% |
174,512
-164,389
| -49% | -$4.19M |
|
|
TRUE
1823
DELISTED
TrueCar
TRUE
| $4.48M | ﹤0.01% |
820,499
+220,382
| +37% | +$1.35M |
|
1824
Coherus Oncology
CHRS
$217M
| $4.47M | ﹤0.01% |
202,558
-797,414
| -80% | -$13.8M |
|
|
AIMT
1825
DELISTED
Aimmune Therapeutics
AIMT
| $4.47M | ﹤0.01% |
215,024
+63,754
| +42% | +$1.31M |
|
Similar funds
Deutsche Bank's Q2 2019 Portfolio in Review
As of Q2 2019, Deutsche Bank held 5,752 positions worth $170B, up 1.4% from $168B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Deutsche Bank's Q2 2019 filing shows 505 new, 1,733 increased, 2,692 reduced and 359 closed positions. Its largest new stake was Dow Inc: 4,564,990 shares worth $225M. The largest sale was VanEck Gold Miners ETF, an estimated $765M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q2 2019 buy was Dow Inc: 4,564,990 shares worth $225M.
- Deutsche Bank added most to Medtronic in Q2 2019, an estimated $870M increase.
- Deutsche Bank's biggest Q2 2019 reduction was Charter Communications, cutting an estimated $572M.
- Deutsche Bank fully exited VanEck Gold Miners ETF in Q2 2019, selling an estimated $765M.
- Deutsche Bank's ten largest holdings make up 14% of its $170B portfolio in Q2 2019.
- Deutsche Bank opened 505 new positions and closed 359 in Q2 2019.
- Deutsche Bank's portfolio value rose 1.4% quarter-over-quarter to $170B.
Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.